Data / Drug companies / Pemetrexed disodium
Pemetrexed disodium: 14 companies and 44 products in the FDA NDC directory
Pemetrexed disodium is listed in the FDA National Drug Code Directory by 14 companies, with 44 products in commercial distribution. 33 of the products (75.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, powder, lyophilized, for solution; injection; injection, solution, and the newest product started marketing on April 15, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 44
- Generic (ANDA) products
- 33 (75.0%)
- Application numbers
- 13
- Routes
- Intravenous
- Brand names
- Pemetrexed, Pemrydi Rtu, Alimta
- openFDA record search
- api.fda.gov
Companies that list pemetrexed disodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Meitheal Pharmaceuticals Inc. | 8 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 13, 2022 |
| BluePoint Laboratories | 6 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | February 28, 2023 |
| Fresenius Kabi USA, LLC | 4 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 25, 2022 |
| Amneal Pharmaceuticals LLC | 3 | injection | New drug applications (NDA) | June 6, 2023 |
| Dr. Reddy's Laboratories Inc. | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 25, 2022 |
| Sandoz Inc | 3 | injection, solution | New drug applications (NDA) | June 8, 2022 |
| Shilpa Medicare Limited | 3 | injection | New drug applications (NDA) | January 1, 2024 |
| Camber Pharmaceuticals, Inc. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 14, 2024 |
| Eli Lilly and Company | 2 | injection, powder, lyophilized, for solution | New drug applications (NDA) | September 7, 2007 |
| NorthStar RxLLC | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 1, 2024 |
| Qilu Pharmaceutical Co., Ltd. | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 25, 2022 |
| Sagent Pharmaceuticals | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 15, 2024 |
| Somerset Therapeutics, LLC | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 15, 2025 |
| Waverley Pharma Inc | 2 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 4, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, lyophilized, for solution | 35 | 79.5% |
| Injection | 6 | 13.6% |
| Injection, solution | 3 | 6.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 33 | 75% |
| New drug applications (NDA) | 11 | 25% |
Pharmacologic classes
| Class | Products |
|---|---|
| Folate Analog Metabolic Inhibitor | 44 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.